Hand-Held Personal Digital Assistant Program for the HEMOCHRON® RxDx® Heparin and Protamine Dosing System

Journal of Extra-Corporeal Technology

Volumn 35, Issue 3, 2003, Pages 212-217

  El Rouby, Soumaya ^a,b   Rinehart, Kristin ^a   Zucker, Marcia L ^a   LaDuca, Frank M ^a  

^a International Technidyne Corporation   (United States)

^b NONE   (United States)

Author keywords

Cardiac surgery; Hemochron RxDx; Personal digital assistant (PDA)

Indexed keywords

HEPARIN; PROTAMINE;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BODY HEIGHT; BODY WEIGHT; CALCULATOR; COMPUTER PROGRAM; DEVICE; DOSE CALCULATION; DRUG DOSE REGIMEN; EQUIPMENT DESIGN; HEART SURGERY; HUMAN; IN VITRO STUDY; PERFORMANCE;

EID: 0242693299     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Bull BS, Korpman RA, Huse WM, et al. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg. 1975;69:674-84.
2. DeLaria GA, Tyner JJ, Hayes CL, et al. Heparin-protamine mismatch: A controllable factor in bleeding after open-heart surgery. Arch Surg. 1994;129:945-51.
3. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36-45.
4. Bennett KM, Briggins D, Zucker ML, et al. A four-year experience with patient individualized heparin and protamine dosing using the Hemochron RxDx system. J ExtraCorp Technol. 2001;33:19-22.
5. Allen HT, Peng MT, Chen KP, et al. Prediction of blood volume and adiposity in man from body weight and cube of height. Metabolism. 1956;5:328-45.
6. Zucker ML, Barrett CL, Bennett K, et al. Utility of in vitro heparin and protamine titration for dosing during cardiopulmonary bypass surgery. J ExtraCorp Technol. 1997;29:176-80.